What is aTyr Pharma's other commercial liabilities?

aTyr Pharma (ATYR) reported other commercial liabilities of $7.46M in Q1 2026.

How has aTyr Pharma's other commercial liabilities changed year-over-year?

aTyr Pharma's other commercial liabilities decreased by 5.1% year-over-year, from $7.86M to $7.46M.

What is the long-term trend for aTyr Pharma's other commercial liabilities?

Over 5 years (2020 to 2025), aTyr Pharma's other commercial liabilities has grown at a 22.3% compound annual growth rate (CAGR), from $3.57M to $9.79M.

aTyr Pharma ATYR Other Commercial Liabilities

Other Commercial Liabilities at other companies

CytomX TherapeuticsCTMX

——

Vor BiopharmaVOR

——

Oric Pharmaceuticals, Inc.ORIC

——

Viridian Therapeutics, Inc.VRDN

——

Nuvation BioNUVB

——

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's other commercial liabilities?: aTyr Pharma (ATYR) reported other commercial liabilities of $7.46M in Q1 2026.
How has aTyr Pharma's other commercial liabilities changed year-over-year?: aTyr Pharma's other commercial liabilities decreased by 5.1% year-over-year, from $7.86M to $7.46M.
What is the long-term trend for aTyr Pharma's other commercial liabilities?: Over 5 years (2020 to 2025), aTyr Pharma's other commercial liabilities has grown at a 22.3% compound annual growth rate (CAGR), from $3.57M to $9.79M.